REQUEST A DEMO
Total
USD $0.00
Search more companies

Lupin Philippines, Inc. (Philippines)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Lupin Philippines, Inc. Profile Updated: February 20, 2026
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English Download a sample report

Lupin Philippines, Inc. is based in Philippines, with the head office in City Of Makati. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on December 20, 2010. There was a net sales revenue increase of 185.35% reported in Lupin Philippines, Inc.’s latest financial highlights for 2024. There was a total growth of 126.89% in Lupin Philippines, Inc.’s total assets over the same period.

Headquarters
Unit 26-C 26Th Floor, Rufino Pacific Tower
City Of Makati; Fourth District, National Capital Region (Ncr);

Contact Details: Purchase the Lupin Philippines, Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Lupin Philippines, Inc. report to view the information.
Incorporation Date:
December 20, 2010
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Generic Health Pty Ltd (Australia)
100%
Generic Health Sdn. Bhd. (Malaysia)
100%
Lupin Inc. (United States)
100%
Company Performance
Financial values in the chart are available after Lupin Philippines, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
185.35%
Total Operating Revenue
185.35%
Net Profit/Loss for the Period
N/A
Total Assets
126.89%
Total Equity
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
878.75%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?